Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06544798 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial
NCT06544798 · ClinicalTrials.gov record · last posted 2025-10-16

Long-term Follow-up of Gene Therapy for Radiation-Induced Xerostomia

StatusEnrolling by Invitation
PhasePhase 2
Started2024-08-02
View on ClinicalTrials.gov ↗
from the ClinicalTrials.gov record
This study will assess the long-term safety and efficacy of bilateral intra-parotid administration of AAV2-hAQP1 in adults with Grade 2 or Grade 3 radiation-induced late xerostomia.

Amendment record 1 amendment on the ClinicalTrials.gov record

This ClinicalTrials.gov record has been amended once since 2024-08-05. DataLookout shows field-level changes from the day a trial enters its daily monitoring; earlier amendments are counted here from the ClinicalTrials.gov version history. See every version on ClinicalTrials.gov ↗

Trial Details
NCT Number NCT06544798
Lead Sponsor MeiraGTx, LLC
Conditions Grade 2 and 3 Late Xerostomia Caused by Radiotherapy for Cancers of the Upper Aerodigestive Tract, Excluding the Parotid Glands
Enrollment 276 participants
Start Date 2024-08-02
Primary Completion 2032-02 (estimated)
Study Completion 2032-02 (estimated)
Updated on ClinicalTrials.gov 2025-10-16